Going concern
Filing comparison
Envoy Medical, Inc. disclosed substantial doubt about its ability to continue as a going concern
Substantial doubt raised, alleviated by management's plans → Substantial doubt about ability to continue as a going concern
Liquidity and Going Concern Since inception, the Company has historically incurred negative operating cash flows and losses from operations as the Company advances the clinical development of its products and the funding process of clinical FDA trials. These matters raise substantial doubt about the Company’s ability to continue as a going concern and although management has developed plans intended to support ongoing operations, such plans do not alleviate the substantial doubt. As of June 30, 2026, the Company has an accumulated deficit of $326,369. On various dates in 2025, the Company…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- substantial_doubt
- Current state label
- Substantial doubt about ability to continue as a going concern
- Direction
- escalated
- Located in
- going-concern note
- Prior filed
- 2026-05-11
- Prior form
- 10-Q
- Prior state
- doubt_alleviated
- Prior state label
- Substantial doubt raised, alleviated by management's plans
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.